The Business Research Company’s report on the Coronary Artery Disease Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the coronary artery disease market?
The rise in the prevalence of coronary artery disease is expected to propel the growth of the coronary artery disease market over the coming years. Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others. Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. For instance, in May 2024, according to Centre of Disease control and prevention, a US-based federal agency within the U.S. Department of Health and Human Services, coronary heart disease (CHD) was the leading type of heart disease, causing 371,506 deaths in 2022. Around 5% of adults aged 20 and older (1 in 20) had coronary artery disease (CAD). In 2022, about 1 in 5 cardiovascular disease (CVD) deaths occurred in adults younger than 65 years old. Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.
Access Your Free Sample of the Global Coronary Artery Disease Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp
How has the coronary artery disease market size evolved, and what are the latest forecasts for its expansion?
The coronary artery disease market size has grown strongly in recent years. It will grow from $29.15 billion in 2024 to $31.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to prevalence of coronary artery disease, growth in minimally invasive surgeries, increase in sedentary lifestyles, aging population and cad prevalence, evolution of pharmacological treatments
The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $48.48 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to growing lifestyle factors, focus on telemedicine and remote monitoring, expansion of interventional cardiology procedures, shift towards value-based healthcare models, and development of novel drug therapies. Major trends in the forecast period include the development of gene therapies, integration of artificial intelligence in diagnosis, focus on mental health in CAD care, rise in home-based healthcare services, and adoption of remote cardiac rehabilitation.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp
Which major companies dominate the coronary artery disease market?
Major companies operating in the coronary artery disease market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.
What trends will shape the future of the coronary artery bypass graft market?
Major companies operating in the coronary artery disease market are focusing on developing advanced technologies, such as AI-based blood tests, to gain a competitive edge in the market. An AI-based blood test refers to a diagnostic test that incorporates artificial intelligence (AI) algorithms in the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based AI-based integrated genetic-epigenetic engine manufacturing company, announced the launch of PrecisionCHD. It’s a combined genetic and epigenetic blood test designed for the early identification of coronary heart disease. PrecisionCHD exhibits over 75% sensitivity for the detection of coronary heart disease in both men and women. Utilizing a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, the test incorporates epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.
Which region dominates the coronary artery disease market, and what factors contribute to its leadership?
North America was the largest region in the coronary artery disease market in 2024. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
How is the coronary artery disease market segmented, and which segment holds the largest share?
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors, Other Medications
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery, Other Surgical Interventions
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12052
How is the coronary artery disease market defined?
Coronary artery disease (CAD) is a medical condition that affects the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Coronary artery disease occurs when arteries become narrowed or blocked due to plaque buildup, a substance composed of cholesterol, fat, calcium, and other substances.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
